Regulation of HHLA2 expression in renal cell carcinoma and myeloid cells

被引：0
|
作者：
Shigemura, Tomonari [1 ]
Perrot, Nahuel [2 ]
Huang, Zimo [2 ]
Sheshdeh, Aseman Bagheri [3 ]
El Ahmar, Nourhan [3 ]
McDermott, David [2 ]
Signoretti, Sabina
Freeman, Gordon [1 ]
Mahoney, Kathleen [4 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
CANCER RESEARCH | 2023年 / 83卷 / 16期
关键词：
D O I：
10.1158/1538-7445.KIDNEY23-A005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A005
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
    Daisaku Nishihara
    Toshiki Kijima
    Kyoko Arai
    Takao Kamai
    International Urology and Nephrology, 2023, 55 : 867 - 874
  • [22] HHLA2 Expression Demonstrated by Immunohistochemistry in Non-Ductal Pancreatic Tumors
    de Gonzalez, Anne K. Koehne
    Yan, Han
    Su, Gloria H.
    Remotti, Helen
    LABORATORY INVESTIGATION, 2018, 98 : 681 - 681
  • [23] HHLA2 Expression Demonstrated by Immunohistochemistry in Non-Ductal Pancreatic Tumors
    de Gonzalez, Anne K. Koehne
    Yan, Han
    Su, Gloria H.
    Remotti, Helen
    MODERN PATHOLOGY, 2018, 31 : 681 - 681
  • [24] HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma (vol 8, e000157, 2020)
    Zhou, Q.
    Li, K.
    Chen, X.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [25] The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma
    Dawei Zhu
    Yingting Liu
    Junjun Chen
    Qi Wang
    Yuan Li
    Yulan Zhu
    Jun Feng
    Jingting Jiang
    Journal of Translational Medicine, 20
  • [26] Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma
    Li, Wenjing
    You, Jianqing
    Xue, Haixiang
    Liu, Yi
    Chen, Junjun
    Zheng, Xiao
    Chen, Lujun
    Wu, Changping
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (10)
  • [27] Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
    Xu, Lijuan
    Li, Fengsen
    Jiang, Min
    Li, Zheng
    Xu, Dan
    Jing, Jing
    Wang, Jing
    Ding, Jianbing
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 139 - 153
  • [28] The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma
    Zhu, Dawei
    Liu, Yingting
    Chen, Junjun
    Wang, Qi
    Li, Yuan
    Zhu, Yulan
    Feng, Jun
    Jiang, Jingting
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [29] Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
    Ding, Lin
    Yu, Qian
    Yang, Shuo
    Yang, Wen-Jing
    Liu, Te
    Xian, Jing-Rong
    Tian, Tong-Tong
    Li, Tong
    Chen, Wei
    Wang, Bei-Li
    Pan, Bai-Shen
    Zhou, Jian
    Fan, Jia
    Yang, Xin-Rong
    Guo, Wei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] Evaluating the combined role of HHLA2 and PD-L1 as biomarkers in first-line nivolumab therapy in advanced clear cell renal cell carcinoma.
    Laimon, Yasmin Nabil
    El Ahmar, Nourhan
    Jegede, Opeyemi
    Sheshdeh, Aseman Baghari
    Freeman, Gordon J.
    Mcdermott, David F.
    Atkins, Michael B.
    Signoretti, Sabina
    Mahoney, Kathleen Margaret
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345